Procedures Required to Accomplish Complete Cytoreduction of Ovarian Cancer: Is There a Correlation with “Biological Aggressiveness” and Survival?
- 1 September 2001
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 82 (3), 435-441
- https://doi.org/10.1006/gyno.2001.6313
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Second-Look Laparotomy for Ovarian Cancer Provides Reliable Prognostic Information and Improves SurvivalGynecologic Oncology, 1997
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- The Influence of Tumor Grade, Distribution, and Extent of Carcinomatosis in Minimal Residual Stage III Epithelial Ovarian Cancer after Optimal Primary Cytoreductive SurgeryGynecologic Oncology, 1994
- Peritoneal Implant Elimination during Cytoreductive Surgery for Ovarian Cancer: Impact on SurvivalGynecologic Oncology, 1993
- The Validity and Significance of Substages of Advanced Ovarian CancerGynecologic Oncology, 1993
- Occult pleural involvement in Stage III ovarian carcinoma: Role of diaphragm resectionGynecologic Oncology, 1990
- Electrosurgical debulking of ovarian cancer: A new technique using the argon beam coagulatorGynecologic Oncology, 1990
- Primary surgical therapy of ovarian cancer: How much and whenGynecologic Oncology, 1990
- Resection of diaphragmatic peritoneum and muscle: Role in cytoreductive surgery for ovarian cancerGynecologic Oncology, 1989
- Debulking surgery for ovarian cancer with the Cavitron Ultrasonic Surgical Aspirator (CUSA)—A preliminary reportGynecologic Oncology, 1988